MM
Mcglynn Margaret G
Director
OFFICERF
179.910 €
▼ Ventas (1 oper.)
Historial del iniciado
DirectivoTodavía no hay suficientes señales de compra con un horizonte T+90 consolidado para medir un historial.
Browse the detailed record of transactions filed by Mcglynn Margaret G, Director. Insider active across 4 companies, notably Amicus Therapeutics, INC.. Aggregated, 22 disclosures have been recorded. Split: 0 buy · 1 sell. Total volume traded: €180k. History available since 1 May 2021. The latest transaction was disclosed on 27 April 2026 (Disposition). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Mcglynn Margaret G
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declaraciones22 en total
94.631 títulos@ 14,50 US$0.029% mcap75.7% de su flujoCommon StockSEC:0001193125-26-182284:0
10.420 títulos0Common StockSEC:0001593968-25-000784:0
20.414 títulos0Common StockSEC:0000950170-25-083225:0
2029 títulos@ 4,90 US$100.0% de su flujoCommon StockSEC:0001104659-25-009785:0
6670 títulos0Common StockSEC:0001593968-24-000865:0
11.847 títulos0Common StockSEC:0000950170-24-071002:0
7500 títulos@ 2,80 US$5.2% de su flujoCommon StockSEC:0000950170-24-027334:0
3100 títulosCommon StockSEC:0001209191-23-036754:0
8584 títulos0Common StockSEC:0001209191-23-036434:0
15.000 títulos@ 3,32 US$12.2% de su flujoCommon StockSEC:0001209191-23-003573:0
15.000 títulos@ 13,0258 US$47.9% de su flujoCommon StockSEC:0001209191-23-003573:1
700 títulosCommon StockSEC:0001209191-22-038594:0
12.671 títulos0Common StockSEC:0001209191-22-035836:0
15.000 títulos@ 4,79 US$0.0015% mcap52.3% de su flujoCommon StockSEC:0001209191-22-027245:0
921 títulosCommon StockSEC:0000899243-22-016336:0
5000 títulos@ 127,54 US$0.0005% mcap25.4% de su flujoCommon StockSEC:0000899243-22-014548:0
5000 títulos@ 127,54 US$0.0005% mcap25.0% de su flujoCommon StockSEC:0000899243-22-013305:0
5000 títulos@ 127,54 US$0.0005% mcap24.8% de su flujoCommon StockSEC:0001209191-22-005895:0
10.115 títulos0Common StockSEC:0001209191-21-040392:0
699 títulosCommon StockSEC:0001209191-21-037619:0
10.000 títulos@ 7,51 US$4.0% de su flujoCommon StockSEC:0001209191-21-030441:0
921 títulos0Common StockSEC:0001209191-21-029861:0
About Mcglynn Margaret G
MCGLYNN MARGARET G is Director at Amicus Therapeutics, INC., Vertex Pharmaceuticals INC / MA and NOVAVAX INC. They have filed 22 disclosures in total. In the sampled recent filings, sales amount to EUR 1350340, over the period from 2021-05-04 to 2026-04-27, and the most frequent transaction nature is Exercise of options.